[Results of treating tubal factors in infertile women in light of successful pregnancies].

Ginekologia polska · 1993 · vol. 64(11) , pp. 557–61 · PMID:8112629 · W2396393005
article OA: closed CC0
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-13

This study analyzed 80 successful pregnancies in women treated for tubal infertility, finding that pregnancy rates were influenced by infertility duration, treatment length, patient age, and the underlying cause and surgical intervention.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We retrospectively analyzed 80 pregnancies ended by delivery of a healthy child in women after treatment of tubal infertility. The results were influenced by the duration of infertility, duration of the treatment and by the age of the patients. 13.75% of women with clinical symptoms of chronic exacerbate inflammation became pregnant after preliminary anti-inflammatory treatment but 86.25% of women following treatment due to earlier determined etiology (endometriosis, post inflammatory tubal disease). The group of women (38.75%) with oviductal occlusion apart from the treatment based on etiology were also treated surgically in 70%.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Infertility, Female Adult Animals Anti-Inflammatory Agents Anti-Inflammatory Agents Endometriosis Endometriosis Fallopian Tubes Fallopian Tubes Female Humans Infertility, Female Retrospective Studies Treatment Outcome

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-03T06:10:56.557307+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:34.315996+00:00
License: CC0 · commercial use OK